Postconditioning hormesis put in perspective: An overview of experimental and clinical studies

Dose-Response

Volumn 9, Issue 2, 2011, Pages 209-224

  Wiegant, F A C ^a   Prins, H A B ^a   van Wijk, R ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b International Institute of Biophysics   (Germany)

Author keywords

Adaptive response; Hormesis; Postconditioning; Postexposure; Preconditioning

Indexed keywords

ALLERGEN; ARSENIC TRIOXIDE; BCG VACCINE; CADMIUM; COPPER; DIETHYLDITHIOCARBAMIC ACID; GLUTAMIC ACID; HEAT SHOCK PROTEIN; LEAD; MENADIONE; MERCURY; MUSTARD GAS;

ARTICLE; BCG VACCINATION; BODY EQUILIBRIUM; BRAIN INJURY; CANCER RADIOTHERAPY; CELL ACTIVITY; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL SPECIFICITY; CELL STRESS; CELL SURVIVAL; CLINICAL ASSESSMENT; CLINICAL STUDY; CONCENTRATION RESPONSE; DRUG TARGETING; ENVIRONMENTAL FACTOR; EXERCISE; EXPERIMENTAL STUDY; HEALTH STATUS; HEART INFARCTION; HEART PROTECTION; HEAT SHOCK; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOMEOSTASIS; HORMESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTENSION; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; IN VITRO STUDY; INFECTION SENSITIVITY; INFLAMMATION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; MOLECULAR DYNAMICS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; POSTCONDITIONING HORMESIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RADIATION DOSE; REPERFUSION INJURY; RISK REDUCTION; THERAPY EFFECT; TREATMENT OUTCOME; TUBERCULOSIS; VACCINATION; VIRUS INFECTION; VIRUS LOAD; WHOLE BODY RADIATION;

EID: 79958754294     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.10-004.Wiegant     Document Type: Article

References (75)

1. Agutter PS. 2008. Elucidating the mechanism(s) of hormesis at the cellular level: the universal cell response. Am J Pharmacol Toxicol 3: 97-107.
2. Antonovsky A. 1979. Health, stress and coping. Jossey-Bass, San Francisco.
3. Bellavite P, Conforti A, Pontarollo F and Ortolani R. 2006a. Immunology and homeopathy. 2. Cells of the immune system and inflammation. eCAM 3: 13-24.
4. Bellavite P, Ortolani R and Conforti A. 2006b. Immunology and homeopathy. 3. Experimental studies on animal models. eCAM 3: 171-186.
5. Calabrese EJ and Baldwin LA. 1998. Hormesis as a biological hypothesis. Env Health Persp 106: 357- 362.
6. Calabrese EJ and Baldwin LA. 2002a. Defining hormesis. Hum Exp Toxicol 21: 91-97.
7. Calabrese EJ and Baldwin LA. 2002b. Applications of hormesis in toxicology, risk assessment and chemotherapeutics. Trends Pharm Sci 23: 331-337.
8. Calabrese EJ and Baldwin LA. 2003. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol 43: 175-197.
9. Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Cedergreen N, Cherian MG, Chiueh CC, Clarkson TW, Cook RR, Diamond DM, Doolittle DJ, Dorato MA, Duke SO, Feinendegen L, Gardner DE, Hart RW, Hastings KL, Hayes AW, Hoffmann GR, Ives JA, Jaworowsk, Z, Johnson TE, Jonas WB, Kaminski NE, Keller JG, Klaunig JE, Knudsen TB, Kozumbo WJ, Lettieri T, Liu S-Z, Maisseu A, Maynard KI, Masoro EJ, McClellan RO, Mehendale HM, Mothersill C, Newlin DB, Nigg HN, Oehme FW, Phalen RF, Philbert MA, Rattan SIS, Riviere JE, Rodricks J, Sapolsky RM, Scott BR, Seymour C, Sinclair DA, Smith-Sonneborn J, Snow ET, Spear L, Stevenson DE, Thomas Y, Tubiana M, Williams GM and Mattson MP. 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222: 122-128.
10. Calabrese EJ. 2008a. Converging concepts: Adaptive response, preconditioning, and the Yerkes- Dodson law are manifestations of hormesis. Ageing Res Rev 7: 8-20.
11. Calabrese EJ. 2008b. Hormesis: Why is it important to toxicology and toxicologists. Env Toxicol Chem 27: 1451-1474.
12. Charlton BG. 1996. A new science of health: salutology and the evolutionary perspective. Q J Med 89: 233-236.
13. Connolly NC, Whiteside TL, Wilson S, Kondragunta V, Rinaldo CR and Riddler SA. 2008. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Clin Vaccine Immunol 15: 284-292.
14. Csermely P and Vigh L (eds). 2007. Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks. Landes Bioscience and Springer Science+Business media, New York.
15. Darling CE, Solari PB, Smith CS, Furman MI and Przyklenk K. 2007. Postconditioning the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 102: 274-278.
16. Davies PG. 2007. Between health and illness. Persp Biol Med 50: 444-452.
17. Delpino A, Gentile FP, Di Modugno F, Benassi M, Mileo AM and Mattei E. 1992. Thermo-sensitization, heat shock protein synthesis and development of thermotolerance in M-14 human tumor cells subjected to step-down heating. Radiat Environ Biophys 31: 323-332.
18. Ellis RJ. 2007. Protein misassembly: macromolecular crowding and molecular chaperones. In: Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks. (P. Csermely and L. Vigh (eds.)). Landes Bioscience and Springer Science+Business Media. New York. Pp 1-13.
19. Girinsky T, Guillot-Vals D, Koscielny S, Cosset JM, Ganem G, Carde P, Monhonval M, Pereira R, Bosq J, Ribrag V, Vantelon JM, Munck JN. 2001. A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. Int J Radiat Oncol Biol Phys 51: 148-155.
20. Goossens L, Sunaert S, Peeters R, Griez EJL, Schruers KRJ. 2007. Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psych 62: 1119-1125.
21. Gregersen N, Bross P, Vang S and Christensen JH. 2006. Protein misfolding and human disease. Annu Rev Genomics Hum Genet 7: 103-124.
22. Hagberg JM, Park J-J and Brown MD. 2000. The role of exercise training in the treatment of hypertension: an update. Sports Med 30: 193-206.
23. Hariri AR, Bookheimer SY and Mazziotta JC. 2000. Modulating emotional responses: Effects of a neocortical network on the limbic system. Neuroreport 11: 43-48.
24. Hashimoto S, Shirato H, Hosokawa M, Nishioka T, Kuramitsu Y, Matushita K, Kobayashi M and Miyasaka K. 1999. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Rad Res 151: 717-724.
25. Hightower LE. 1991. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66: 191-197.
26. Inserte J, Barba I, Hernando V, Abellán A, Ruiz-Meana M, Rodríguez-Sinovas A and Garcia-Dorado D. 2008. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res 77: 782-790.
27. Ito M, Shibamoto Y, Avakwa S, Tomita N, Sugie C and Ogino H. 2008. Effect of low-dose total-body irradiation on transplantability of tumor cells in syngeneic mice. J Rad Res 49: 197-201.
28. Ives J, Jonas W, Hartings J. et al. 2001. Neuroprotection in experimental rat brain injury with ultra high dilution glutamate but not potassium chloride. Soc Neurosci Abstr 27: 557.
29. Jackson GG, Perkins JT, Rubenis M, Paul DA, Knigge M, Despotes JC and Spencer P. 1988. Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. Lancet 2(8612): 647-652.
30. Jonas WB, Lin Y, Williams A, Tortella F and Tuma R. 1999. Treatment of experimental stroke with low-dose glutamate and homeopathic Arnica Montana. Perfusion 12, 452-462.
31. Jonas WB, Lin Y and Tortella F. 2001. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuro Reports 12: 335-339.
32. Jonas WB and Ives JA. 2008. Should we explore the clinical utility of hormesis? Hum Exp Toxicol 27: 123-127.
33. Karpas A, Gillson W, Bevan PC and Oates JK. 1985. Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies. Lancet 2(8457): 695-697.
34. Karpas A, Hill F, Youle M, Cullen V, Gray J, Byron N, Hayhoe F, Tenant-Flowers M, Howard L, Gilgen D, Oates JK, Hawkins D and Gazzard B.1988. Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci USA 85: 9234-9239.
35. Kennerdell JS, Flores NE and Hartsock RJ. 1999. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa. Ophthal Plast Reconstr Surg 15: 129-133.
36. Laskey WK. 2005. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65: 361-367.
37. Liem DA, Honda HM, Zhang J, Woo D and Ping P. 2007. Past and present course of cardioprotection against ischemia-reperfusion injury. J Appl Physiol 103: 2129-2136.
38. Lindström B and Eriksson M. 2005. Salutogenesis. J Epidemiol Comm Health 59: 440-442.
39. Marotta D, Marini A, Banaudha K, Maharaj SV and Jonas WB. 2002. Non-linear effects of cycloheximide in glutamate treated cultured rat cerebellar neurons. Neurotoxicol 23: 307-312.
40. Mattson MP. 2008. Hormesis and disease resistance: activation of cellular stress response pathways. Hum Exp Toxicol 27: 155-162.
41. Morimoto RI. 2008. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427-1438.
42. Ovelgönne JH, Wiegant FAC, Souren JEM, Van Rijn J and Van Wijk R. 1995. Enhancement of the stress response by low concentrations of arsenite in arsenite-pretreated H35 hepatoma cells. Toxicol Appl Pharmacol 132: 146-155.
43. Parsons TD and Rizzo AA. 2008. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry 39: 250-261.
44. Paterson J. 1944. Report on mustard gas experiments. J Am Homoeop Assoc 37: 47-50/37: 88-89.
45. Pinheiro AR, Cunha AR, Aguila MB and Mandarim-de-Lacerda CA. 2007. Beneficial effects of physical exercise on hypertension and cardiovascular adverse remodeling of diet-induced obese rats. Nutr Metab Cardiovasc Res 17: 365-375.
46. Plotkin SA. 1999. Vaccination against the major infectious diseases. C R Acad Sci III 322: 943-951.
47. Rapp DJ. 1978. Double-blind confirmation and treatment of milk sensitivity. Med J Aust 1: 571-572.
48. Richaud PM, Soubeyran P, Eghbali H, Chacon B, Marit G, Brouset A and Hoerni B. 1998. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 40: 387-390.
49. Rothbaum BO and Schwartz AC. 2002. Exposure therapy for posttraumatic stress disorder. Am J Psychother 56: 59-75.
50. Ryan JA and Hightower LE. 1996. Stress proteins as molecular biomarkers for environmental toxicology. EXS. 77: 411-424.
51. Sällberg M, Weiland M and Frelin L. 2007. Therapeutic vaccines: challenges of chronic viral infections. Drug Disc Today: Therap Strateg 4: 253-266.
52. Schamhart DHJ, Zoutewelle G, Van Aken H and Van Wijk R. 1992. Effects on the expression of heat shock proteins by step-down heating and hypothermia in rat hepatoma cells with a different degree of heat sensitivity. Int J Hyperthermia 8: 701-716.
53. Serviddio G, Romano AD, Gesualdo L, Tamborra R, Di Palma AM, Rollo T, Altomare E and Vendemiale G. 2008. Postconditioning is an effective strategy to reduce renal ischemia/reperfusion injury. Nephrol Dial Transpl 23: 1504-1512.
54. Skyschally A, Van Caster P, Iliodromitis EK, Schulz R, Kremastinos DT and Heusch G. 2009. Ischemic postconditioning: experimental models and protocol algorithms. Basic Res Cardiol 104: 469-483.
55. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT and L'Huillier I. et al. 2005. Postconditioning the human heart. Circulation 112: 2143-2148.
56. Stebbing ARD. 2003. A mechanism for hormesis - a problem in the wrong discipline. Crit Rev Toxicol 33: 463-467.
57. Szeto AL, Rollwagen F and Jonas WB. 2004. Rapid induction of protective tolerance to potential terrorist agents: a systematic review of low- and ultra-low dose research. Homeopathy 93: 173-178.
58. Thayer KA, Melnick R, Burns K, Davis D and Huff J. 2005. Fundamental flaws of hormesis for public health decisions. Env Health Persp 113: 1271-1275.
59. Tipton CM, Matthes RD, Marcus KD, Rowlett KA and Leininger JR. 1983. Influences of exercise intensity, age, and medication on resting systolic blood pressure of SHR populations. J Appl Physiol 55: 1305-1310.
60. Van Wijk R, Ovelgönne JH, de Koning E, Jaarsveld K, Van Rijn J, Wiegant FAC. 1994a. Mild step-down heating causes increased transcription levels of hsp68 and hsp84 mRNA and enhances thermotolerance development in Reuber H35 hepatoma cells. Int J Hyperthermia 10: 115-125.
61. Van Wijk R, Ooms H, Wiegant FAC, Souren JEM, Ovelgönne JH, Van Aken JM, and Bol AWJM. 1994b. A molecular basis for understanding the benefits from subharmful doses of toxicants. Environm Management and Health 5: 13-25.
62. Van Wijk R and Wiegant FAC. 2006. The Simila Principle. An Experimental Approach on the Cornerstone of Homeopathy. Karl und Veronica Carstens-Stiftung, Essen.
63. Van Wijk R and Wiegant FAC. 2010. Post-conditioning hormesis and the homepathic similia principle: molecular aspects. Human Exp Toxicol 29: 561-565.
64. Vittecoq D, Chevret S, Morand-Joubert L, Heshmati F, Audat F, Bary M, Dusautoir T, Bismuth A, Viard JP and Barré-Sinoussi F. 1995. Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Proc Natl Acad Sci USA 92: 1195-1199.
65. Wang J. 2007. Allergy immunotherapy as an early intervention in patients with child-onset atopic asthma. Pediatrics 120: S148-S149.
66. Wiegant FAC, Souren JEM, Van Rijn J and Van Wijk R. 1994. Stressor-specific induction of heat shock proteins in rat hepatoma cells. Toxicology 94: 143-159.
67. Wiegant FAC, Spieker N, Van der Mast CA and Van Wijk R. 1996. Is heat shock protein re-induction during tolerance related to the stressor-specific induction of heat shock proteins? J Cell Physiol 169: 364-372.
68. Wiegant FAC, Van Rijn J and Van Wijk R. 1997. Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cells. Toxicology 116: 27-37.
69. Wiegant FAC, Spieker N and Van Wijk R. 1998. Stressor-specific enhancement of hsp induction by low doses of stressors in conditions of self- and cross-sensitization. Toxicology 127: 107-119.
70. Wiegant FAC, Souren JEM and Van Wijk R. 1999. Stimulation of survival capacity in heat-shocked cells by subsequent exposure to minute amounts of chemical stressors: Role of similarity in hspinducing effects. Hum Exp Toxicol 18: 460-470.
71. Wiegant FAC and Van Wijk R. 2010. The similia principle; results obtained in a cellular model system. Homeopathy 99: 3-14.
72. Wilder J. 1962. Basimetric approach (law of initial value) to biological rhythms. Ann NY Acad Sci 30: 1211-1220.
73. Zhao, ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA and Vinten-Johansen J. 2003. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588.
74. Zhao H. 2007. The protective effect of ischemic postconditioning against ischemic injury: from the heart to the brain. J Neuroimmune Pharmacol 2: 313-318.
75. Zhao H. 2009. Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 29: 873-885.